Mumps Virus Antibody, IgM
Also known as: MUMPS IGM
Use
The Mumps Virus Antibody, IgM test aids in the diagnosis of mumps infection by detecting the presence of IgM antibodies specific to the mumps virus. The presence of IgM antibodies may indicate a current or recent infection. It serves as an important tool for clinicians to confirm or rule out mumps infection in patients presenting with symptoms consistent with the disease.
Special Instructions
Parallel testing with acute and convalescent specimens is preferred. Convalescent specimens must be received within 30 days from receipt of the acute specimens. Mark specimens plainly as 'acute' or 'convalescent.'
Limitations
Low levels of IgM antibody to the mumps virus may occasionally persist for more than 12 months post infection or immunization. The test may produce borderline results that require repeat testing in 10-14 days to confirm. Specimens that are bacterially contaminated, heat-inactivated, hemolyzed, icteric, lipemic, or turbid may be rejected, potentially affecting the validity of the results.
FDA ApprovedNew York Approved
Methodology
Immunoassay (ELISA)
Biomarkers
LOINC Codes
- 25419-3
Result Turnaround Time
1-5 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.2 mL
Container
ARUP standard transport tube
Collection Instructions
Separate serum from cells ASAP or within 2 hours of collection. Transfer serum to an ARUP standard transport tube.
Causes for Rejection
Bacterially contaminated, heat-inactivated, hemolyzed, icteric, lipemic, or turbid specimens.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 48 hours |
| Refrigerated | 2 weeks |
| Frozen | 1 year |